Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Apr;22(4):561-70.
doi: 10.1158/1055-9965.EPI-12-1356. Epub 2013 Mar 27.

Cancer survivors in the United States: prevalence across the survivorship trajectory and implications for care

Janet S de Moor  1 , Angela B Mariotto, Carla Parry, Catherine M Alfano, Lynne Padgett, Erin E Kent, Laura Forsythe, Steve Scoppa, Mark Hachey, Julia H Rowland
Affiliations

Cancer survivors in the United States: prevalence across the survivorship trajectory and implications for care

Janet S de Moor et al. Cancer Epidemiol Biomarkers Prev. 2013 Apr.

Abstract

Background: Cancer survivors represent a growing population, heterogeneous in their need for medical care, psychosocial support, and practical assistance. To inform survivorship research and practice, this manuscript will describe the prevalent population of cancer survivors in terms of overall numbers and prevalence by cancer site and time since diagnosis.

Methods: Incidence and survival data from 1975-2007 were obtained from the Surveillance, Epidemiology, and End Results Program and population projections from the United States Census Bureau. Cancer prevalence for 2012 and beyond was estimated using the Prevalence Incidence Approach Model, assuming constant future incidence and survival trends but dynamic projections of the U.S. population.

Results: As of January 1, 2012, approximately 13.7 million cancer survivors were living in the United States with prevalence projected to approach 18 million by 2022. Sixty-four percent of this population have survived 5 years or more; 40% have survived 10 years or more; and 15% have survived 20 years or more after diagnosis. Over the next decade, the number of people who have lived 5 years or more after their cancer diagnosis is projected to increase approximately 37% to 11.9 million.

Conclusions: A coordinated agenda for research and practice is needed to address cancer survivors' long-term medical, psychosocial, and practical needs across the survivorship trajectory.

Impact: Prevalence estimates for cancer survivors across the survivorship trajectory will inform the national research agenda as well as future projections about the health service needs of this population.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

Figure 1
Figure 1
Estimated and projected number of cancer survivors in the United States from 1977–2022 by years since diagnosis.
Figure 2
Figure 2
Estimated number of cancer survivors in the United States as of January 1, 2012 by cancer site.
Figure 3
Figure 3
Esimated number of cancer survivors in the United States as of January 1, 2012 by time since diagnosis and sex.
Figure 4
Figure 4
Estimated number of cancer survivors in the United States as of January 1, 2012 by cancer site and years from diagnosis.
See this image and copyright information in PMC

References

    1. Howlader N, Noone A, Krapcho M, Neyman N, Aminou R, Waldron W, et al. Bethesda, MD: National Cancer Institute; 2012. Apr, SEER Cancer Statistics Review, 1975–2009 (Vintage 2009 Populations) based on November 2011 SEER data submission, posted to the SEER web site.
    1. Vincent GK, Velkoff VA U.S. Census Bureau. The next four decades : the older population in the United States : 010 to 2050. Washington, D.C.: U.S. Dept. of Commerce, Economics and Statistics Administration, U.S. Census Bureau; 2010.
    1. Parry C, Kent EE, Mariotto AB, Alfano CM, Rowland JH. Cancer survivors: a booming population. Cancer Epidemiol Biomarkers Prev. 2011;20:1996–2005. - PMC - PubMed
    1. Erikson C, Salsberg E, Forte G, Bruinooge S, Goldstein M. Future supply and demand for oncologists : challenges to assuring access to oncology services. J Oncol Pract. 2007;3:79–86. - PMC - PubMed
    1. Chabner BA. Drug shortages--a critical challenge for the generic-drug market. N Engl J Med. 2011;365:2147–2149. - PubMed

MeSH terms